A Hawke's Bay family is celebrating Pharmac's potential funding of Trikafta - a drug that will increase both the quality and length of life of New Zealanders who are living with cystic fibrosis.
Pharmac has also announced it has made NZ the first country to make an application for access to the drug for patients under 12.
It comes after some 18 months of campaigning led by Cystic Fibrosis New Zealand and championed locally by the Fisher family.
Claire Fisher, mum of teenager Amber Fisher who is living with cystic fibrosis, says the progress helps sustain their hope for a possible Trikafta-funded future.
"We will be crossing our fingers that sooner rather than later we hear the amazing news that New Zealand is doing the right thing and ensuring that all Kiwis that can benefit from Trikafta have access to it."